Clinical database management: From raw data through study tabulations to analysis datasets Thank you for your kind introduction, and the opportunity to.

Slides:



Advertisements
Similar presentations
CLINTON W. BROWNLEY AMERICAN UNIVERSITY PH.D. CANDIDATE SEPTEMBER 2, 2009 BRIDGing CDASH to SAS: How Harmonizing Clinical Trial and Healthcare Standards.
Advertisements

ADaM Implementation Guide: It’s Almost Here. Are You Ready?
Communicating with Standards Keeping it Simple Pamela Ryley Vertex Pharmaceuticals, Inc. September 29, 2006.
Industry Issues: Dataset Preparation for Time to Event Analysis Davis Gates Schering Plough Research Institute.
What’s New with CDISC Wayne R. Kubick CDISC CTO.
CDISC ADaM 2.1 Implementation: A Challenging Next Step in the Process Presented by Tineke Callant
The Importance of CDASH
Quick tour of CDISC’s ADaM standard
Kendle Implementation of Clinical Data Acquisition Standards Harmonization Dr Elke Sennewald Kendle 9th German CDISC User Group Meeting Berlin, 28 September.
CDISC (CDASH/SDTM) integration into OC/RDC
An introduction to CDISC and CDASH Bring on the Standards! Emmanuelle Denis M.Sc., MICR Global Health Clinical Trials Research Programme.
Bay Area CDISC Implmentation Network – July 13, 2009 How a New CDISC Domain is Made Carey Smoak Team Leader CDISC SDTM Device Team.
CDISC and how Stata can help us implement it
Beyond regulatory submission - Standards Metadata Management Kevin Lee CDISC NJ Meeting at 06/17/2015 We help our Clients deliver better outcomes, so.
A Taste of ADaM Presented by: Peng/Zik Liu MSD (Shanghai) Pharma Co.
CBER CDISC Test Submission Dieter Boß CSL Behring, Marburg 20-Mar-2012.
© 2011 Octagon Research Solutions, Inc. All Rights Reserved. The contents of this document are confidential and proprietary to Octagon Research Solutions,
How to process data from clinical trials and their open label extensions PhUSE, Berlin, October 2010 Thomas Grupe and Stephanie Bartsch, Clinical Data.
Remapping of Codes (and of course Decodes) in Analysis Data Sets for Electronic Submissions Joerg Guettner, Lead Statistical Analyst Bayer Pharma, Wuppertal,
Implementation of a harmonized, report-friendly SDTM and ADaM Data Flow General by Marie-Rose Peltier Experience by Marie Fournier Groupe Utilisateurs.
Vertex and CDISC / MBC / 12March Vertex and CDISC Accomplishments and Strategy 12 March 2008 Lynn Anderson Associate Director Statistical Programming/Biometrics.
© 2008 Octagon Research Solutions, Inc. All Rights Reserved. 2 Octagon Research Solutions, Inc. Leading the Electronic Transformation of Clinical R&D ©
ODM-SDTM mapping Nicolas de Saint Jorre, XClinical June 20, 2008 French CDISC User Group Bagneux/Paris © CDISC & XClinical, 2008.
1CDISC 2002 RCRIM – Standard Domains Agenda NCI Presentation Standard Domains Working Group Goals Introduction to FDA Information Model (FIM) Discussion:
Overview and feed-back from CDISC European Interchange 2008 (From April 21 st to 25 th, COPENHAGEN) Groupe des Utilisateurs Francophones de CDISC Bagneux.
Second Annual Japan CDISC Group (JCG) Meeting 28 January 2004 Julie Evans Director, Technical Services.
Alun, living with Parkinson’s disease QS Domain: Challenges and Pitfalls Knut Müller UCB Biosciences Conference 2011 October 9th - 12th, Brighton UK.
RCRIM Projects: Protocol Representation and CDISC Message(s) January 2007.
Dave Iberson-Hurst CDISC VP Technical Strategy
Overview of CDISC standards and use cases along the E2E data management process Dr. Philippe Verplancke ESUG Marlow, UK 27 May 2009.
Research based, people driven CDISC ADaM Datasets - from SDTM to submission CDISC Experience Exchange and ADaM Workshop 15 Dec 2008 Zoë Williams, LEO Pharma.
Health IT Workforce Curriculum Version 1.0 Fall Networking and Health Information Exchange Unit 3b National and International Standards Developing.
Clinical Collaboration Platform Overview ST Electronics (Training & Simulation Systems) 8 September 2009 Research Enablers  Consulting  Open Standards.
Preventing Wide and Heavy ADs Dirk Van Krunckelsven Phuse 2011, Brighton ADaM on a Diet.
From PDF to RDF – Representing the CDISC Foundational Standards
© 2011 Clinovo. All Rights Reserved. The contents of this document are confidential and proprietary to Clinovo 1 Clinovo 1208 E. Arques Avenue, Suite 114.
Research Study Data Standards Standards for research study data for submission to regulatory authorities Standard development divided into three parts:
CDISC User Group in Deutschland/Japan Hajime Shimizu (nickname: Akiba) CDISC Japan User Group introduction to team activity.
CDISC – 17/12/2012 Carine Javierre Nathalie SABIN.
1 CDISC HL7 Project FDA Perspective Armando Oliva, M.D. Office of Critical Path Programs FDA.
24 Nov 2007Data Management and Exploratory Data Analysis 1 Yongyuth Chaiyapong Ph.D. (Mathematical Statistics) Department of Statistics Faculty of Science.
© CDISC CDISC Roadmap © CDISC CDISC Strategic Goals #1 Promote and support the continued global adoption of.
How Good is Your SDTM Data? Perspectives from JumpStart Mary Doi, M.D., M.S. Office of Computational Science Office of Translational Sciences Center for.
Generation of real-time SDTM datasets and metadata through a generic SDTM converter mechanism CDISC (CDASH/SDTM) integration into OC/RDC Peter Van Reusel.
Submission Standards: The Big Picture Gary G. Walker Associate Director, Programming Standards, Global Data Solutions, Global Data Management.
Event-Level Narrative
Moving from SAS to Stata: Making customized tables in RTF using -rtfutil- and other packages Thank you for your kind introduction, and the opportunity.
Dave Iberson-Hurst CDISC VP Technical Strategy
Data Standards for Pharmacometric Analysis Data Sets
Traceability Look for the source of your analysis results
Accelerate define.xml using defineReady - Saravanan June 17, 2015.
Secondary Uses Primary Use EHR and other Auhortities Clinical Trial
Clinical Study Results Publication
Beyond regulatory submission - Standards Metadata Management Kevin Lee CDISC NJ Meeting at 06/17/2015 We help our Clients deliver better outcomes, so.
Accenture Accelerated R&D Standards Metadata Management – version control and its governance Kevin Lee CDISC NJ Meeting at 01/28/2015 We help our Clients.
Why use CDISC for trials not submitted to regulators?
Traceability between SDTM and ADaM converted analysis datasets
Quality Control of SDTM Domain Mappings from Electronic Case Report Forms Noga Meiry Lewin, MS Senior SAS Programmer The Emmes Corporation Target: 38th.
Freundschaft Konferenz
In-Depth Report from Optimizing Data Standards Working Group
Patterns emerging from chaos
CDISC UK Network Jun-16 – Welwyn
Fabienne NOEL CDISC – 2013, December 18th
Presenters Emily Woolley
Streamlined Data Collection
Clinical Data Interchange Standards Consortium Overview
An FDA Statistician’s Perspective on Standardized Data Sets
Safety Analytics Workshop – Computational Science Symposium 2019
How Should We Select and Define Trial Estimands
Presentation transcript:

Clinical database management: From raw data through study tabulations to analysis datasets Thank you for your kind introduction, and the opportunity to give this talk. The title of the talk is Clinical database management: From raw data through study tabulations to analysis datasets Si litt om bakgrunn, CRO, akademia, SAS, Stata Inge Christoffer Olsen, Phd Diakonhjemmet Hospital, Norway

Introduction “An experiment is a question which science poses to Nature and a measurement is the recording of Nature's answer” Max Planck I will begin with a quote from the famous physicist Max Planck: ” An experiment is a question which science poses to Nature and a measurement is the recording of Nature's answer” Meaning we cannot understand Nature without measurements. We need to take care of our measurements!

electronic Case Report Form Background Patient Study electronic Case Report Form eCRF Study database SDB

Objective Make the study database Transparent Logical Transferable Ready to analyse

CDISC Clinical Data Interchange Standards Consortium (CDISC) Open Multidisciplinary Neutral Non-profit The CDISC mission is to develop and support global, platform-independent data standards that enable information system interoperability to improve medical research and related areas of healthcare. Standards developed in cooperation with international pharmaceutical, academic and governmental stakeholders Essential for FDA regulatory submissions of new pharmaceuticals

Standards Protocol Clinical Data Acquisition Standards Harmonization (CDASH) eCRF standard Laboratory Data Model (LAB) Standard for exchanging lab-results Study Data Tabulation Model (SDTM) Structure CRF data within pre-specified domains Analysis Data Model (ADaM) Standards for analysis-ready datasets

Idea Protocol CDASH SDTM ADaM Statistical analyses Report

Strengths Standardized programs Recognizable Transferable Potentially very efficient Shown to decrease resources needed by 60% and more if implemented from the protocol on

Weaknesses Rigid Programming demanding Designed to be transferable Text variables No labels, label values or other Stata specific features Extreme long format Not suitable for “non-programmers”

Example STDM Findings class from an Myleaoid Leukemia RCT Note no treatment column STUDYID DOMAIN USUBJID XRSEQ XRTESTCD XRTEST XRCAT XRORRES XRORRESU XRSTRESC XRSTRESN XTSTRESU XRSTAT VISITNUM VISIT TESTSTUDY XR TESTSTUDY-101-02 1 DINTENS In-Patient Days in Intensive Care Unit HOSPITALISATION DAYS 21 Day 21 TESTSTUDY-101-03 2 DREASON In-Patient Days Due to Other Reasons TESTSTUDY-101-04 3 DSTUDY In-Patient Days Due to Study Treatment 22 TESTSTUDY-101-05 4 HOSPITAL Days Hospitalized in this Course TESTSTUDY-101-06 5 BLAST Blasts in Blood TREATMENT RESPONSE 13.11.2010 . TESTSTUDY-101-07 6 BM Bone Marrow NOT DONE TESTSTUDY-101-08 7 NEUT Neutrophils TESTSTUDY-101-09 8 PLAT Platelets TESTSTUDY-101-10 9 RESPONSE Treatment Response NR NO RESPONSE TESTSTUDY-101-11 10 CONDITIO Patient Condition FOLLOW-UP ALIVE 600 Safety Follow up Assessment TESTSTUDY-101-12 11 NEVER Never Had a Remission Y TESTSTUDY-101-13 12 THERAPY Further Anticancer Therapy TESTSTUDY-101-14 13 RELAPSE / SURVIVAL DEAD 701 Survival / Relapse Assessment (MONTH 1) TESTSTUDY-101-15 14 TESTSTUDY-101-16 15

Idea To use the basics from CDISC, but without the rigidity of this approach Use only the SDTM and ADaM utilities Long but not so long Keep Stata labelling features Make accessible for non-programmers

Overview Raw output from eCRF Imported into Stata Tabulation Datasets (TD) All data in semi-standardized datasets No manipulation Analysis Datasets Formatted datasets ready for analyses Possibly manipulated

Examples of TDs tddm: Demographics tdsv: Study visits tdds: Disposition important events during study such as ICF date, randomisation date, study end date, withdrawal date etc. tdtrt: Study treatment information tdie, tdae, tdcm, tdlb, tdvs etc

Examples of ADs adsl: Subject level analysis dataset adds: Disposition treatment, populations, baseline adjustments variables adds: Disposition For the patient flow figure adbl: Baseline Demographics and baseline characteristics addisact: Disease activity measures (imputed) For primary and secondary analyses

Discussion I have presented a setup for clinical study databases based on the CDISC standards I find the organisation simple and clear Clear distinction between manipulated and non-manipulated data Transferal of the database should be followed by a document describing the content Reserachers used to one large file might find the number of datasets overwhelming and confusing

The end Thank you!